Heart & Stroke Voice seeks to understand the Irish healthcare landscape and capture how it is perceived by and experienced by those living with or affected by heart and stroke challenges, particularly in terms of equity and access to healthcare. We aim to do this by participating in, contributing to or leading patient-led research; by reviewing and evaluating national and international reports, position papers and healthcare policy publications and engaging with organisations and agencies involved in cardiovascular healthcare in Ireland and Europe.
Stroke is a major cause of mortality and morbidity in our population and a major cost to our health service when outcomes are poor.
Irish National Audit of Stroke National Report 2013-2021
The Irish National Audit of Stroke measures the care for all patients with a stroke in acute hospitals. This audit is showing the key trends in acute stroke care from 2013 to 2021
In the European Union (EU) stroke is the second most common cause of death and a leading cause of adult disability. As populations continue to grow and live to an older age, stroke and the long-term sequelae, along with the corresponding costs, are expected to increase dramatically. This is the third national report from the INAS and it is an overview of the quality of the data and key trends in stroke care from 2013 to 2021. It presents data on 34,630 cases and includes patients aged 17 years and over who were treated in public hospitals that provide acute stroke care and admitted more than 25 patients with a stroke annually from 2013 to 2021. Read more here
Heart & Stroke Voice Ireland is an affiliate of the Global Heart Hub, which is a global alliance of heart patient organizations. The Global Heart Hub recently launched Invisible Nation, a program aimed to expose and respond to the realities of atherosclerotic cardiovascular disease (ASCVD). Leveraging a global network of heart patient organisations and heart patient advocates, and created in partnership with Novartis, Invisible Nation aims to engage with all the stakeholders in cardiovascular diseases.
Invisible Nation will advocate for policy-shaping efforts to rewrite how governments, health systems and all stakeholders can work together to change the trajectory of ASCVD and begin a generational decline in CV death. This program will help reduce the 15 million ASCVD deaths per year and the enormous financial costs of continued
Invisible Nation aims to bring together the cardiovascular community to expose the realities of atherosclerotic cardiovascular disease (ASCVD) – a silent, chronic disease – and the personal and social impact it has. By creating awareness around this major driver of heart attacks, strokes, and death, Invisible Nation intends to ignite conversation, inspire action, and activate systemic change to make the burden of unmanaged ASCVD un-ignorable and expose the barriers for people living with it to reach better health outcomes.
Supported by